Ins and outs of dietary phytochemicals in cancer chemoprevention.

[1]  J. Cerhan,et al.  Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study. , 2006, The American journal of clinical nutrition.

[2]  Phuong Chung,et al.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.

[3]  D. Wallace.  A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[4]  V. Steele,et al.  Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. , 2000, The Journal of nutrition.

[5]  G. Williamson,et al.  Dietary intake and bioavailability of polyphenols. , 2000, The Journal of nutrition.

[6]  M. Sporn.  Approaches to prevention of epithelial cancer during the preneoplastic period. , 1976, Cancer research.

[7]  M. Mcentee,et al.  Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice. , 2004, The Journal of nutrition.

[8]  B. Ames,et al.  Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. , 1983, Science.

[9]  Victor Kipnis,et al.  Could exposure assessment problems give us wrong answers to nutrition and cancer questions? , 2004, Journal of the National Cancer Institute.

[10]  A. Kong,et al.  Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. , 2005, Trends in pharmacological sciences.

[11]  M. Sporn,et al.  Chemoprevention: an essential approach to controlling cancer , 2002, Nature Reviews Cancer.

[12]  K. Bhoola,et al.  Natural products for cancer prevention: a global perspective. , 2003, Pharmacology & therapeutics.

[13]  D. Makuc,et al.  Health, United States, 2003; with chartbook on trends in the health of Americans , 2003 .

[14]  V. Somoza,et al.  Metabolism and bioavailability of trans-resveratrol. , 2005, Molecular nutrition & food research.

[15]  A. Collins.  Antioxidant intervention as a route to cancer prevention. , 2005, European journal of cancer.

[16]  N. Holbrook,et al.  Oxidants, oxidative stress and the biology of ageing , 2000, Nature.

[17]  R. Ghidoni,et al.  Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. , 2005, The Journal of nutritional biochemistry.

[18]  Y. Surh,et al.  Cancer chemoprevention with dietary phytochemicals , 2003, Nature Reviews Cancer.

[19]  Jinsong Liu,et al.  Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.

[20]  L. Barenghi,et al.  Cardiovascular protective effects of resveratrol. , 2006, Cardiovascular drug reviews.

[21]  C. Croce.  How can we prevent cancer? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Giudice,et al.  Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[23]  G. Iacomino,et al.  Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα , 2003, Oncogene.

[24]  B. Reddy,et al.  The Fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  Donna Spiegelman,et al.  Fruit and vegetable intake and risk of major chronic disease. , 2004, Journal of the National Cancer Institute.

[26]  P. Puigserver,et al.  Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.

[27]  J. B. Park,et al.  Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Reber,et al.  Food‐derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis , 2002, International journal of cancer.

[29]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[30]  L. Kolonel,et al.  Intake of Flavonoids and Lung Cancer. , 2000, Journal of the National Cancer Institute.

[31]  E. Campo,et al.  The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. , 2006, Blood.

[32]  C. Rice-Evans,et al.  Modulation of Pro-survival Akt/Protein Kinase B and ERK1/2 Signaling Cascades by Quercetin and Its in Vivo Metabolites Underlie Their Action on Neuronal Viability* , 2003, Journal of Biological Chemistry.

[33]  M R Cullen,et al.  Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. , 1996, Journal of the National Cancer Institute.

[34]  G. Russo,et al.  Quercetin enhances CD95- and TRAIL-induced apoptosis in leukemia cell lines , 2007, Leukemia.

[35]  F. Casagrande,et al.  Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. , 2001, Biochemical pharmacology.

[36]  Arturas Petronis,et al.  Phenotypic differences in genetically identical organisms: the epigenetic perspective. , 2005, Human molecular genetics.

[37]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[38]  W. Bors,et al.  Flavonoids as antioxidants: determination of radical-scavenging efficiencies. , 1990, Methods in enzymology.

[39]  D. Kerr,et al.  Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  A. Broillet,et al.  The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration. , 1983, Xenobiotica; the fate of foreign compounds in biological systems.

[41]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[42]  Edward S. Kim,et al.  Chemoprevention of lung cancer. , 2003, The Lancet. Oncology.

[43]  H. Kamata,et al.  Redox regulation of cellular signalling. , 1999, Cellular signalling.

[44]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[45]  R. Sinha,et al.  Fat, fiber, fruits, vegetables, and risk of colorectal adenomas , 2004, International journal of cancer.

[46]  C. Benz,et al.  Clinical development of histone deacetylase inhibitors as anticancer agents. , 2005, Annual review of pharmacology and toxicology.

[47]  A. Kong,et al.  Antioxidants and oxidants regulated signal transduction pathways. , 2002, Biochemical pharmacology.

[48]  A. Collins,et al.  Absorption and DNA protective effects of flavonoid glycosides from an onion meal , 2000, European journal of nutrition.

[49]  Shishir Shishodia,et al.  Molecular targets of dietary agents for prevention and therapy of cancer. , 2006, Biochemical pharmacology.

[50]  G. Iacomino,et al.  Quercetin and anti‐CD95(Fas/Apo1) enhance apoptosis in HPB‐ALL cell line , 1999, FEBS letters.

[51]  R. Prior.  Fruits and vegetables in the prevention of cellular oxidative damage. , 2003, The American journal of clinical nutrition.

[52]  J. Buttriss,et al.  A review of the epidemiological evidence for the ‘antioxidant hypothesis’ , 2004, Public Health Nutrition.

[53]  T. Okamoto.  Safety of quercetin for clinical application (Review). , 2005, International journal of molecular medicine.

[54]  L. Larocca,et al.  Quercetin inhibits p21‐RAS expression in human colon cancer cell lines and in primary colorectal tumors , 2000, International journal of cancer.

[55]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.

[56]  M. Sporn,et al.  Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research. , 1999, Cancer research.

[57]  B. Halliwell,et al.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? , 2004, British journal of pharmacology.

[58]  J. Stein,et al.  Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. , 2005, Molecular nutrition & food research.

[59]  V. Vogel.  Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[60]  Ivonne M C M Rietjens,et al.  Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. , 2005, Mutation research.

[61]  I. Arts,et al.  SIRT1 stimulation by polyphenols is affected by their stability and metabolism , 2006, Mechanisms of Ageing and Development.

[62]  G. Block,et al.  Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. , 1992, Nutrition and cancer.

[63]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[64]  Edward S. Kim,et al.  Chemoprevention of Cancer , 2004, CA: a cancer journal for clinicians.

[65]  S. Hilsenbeck,et al.  Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[66]  R. Liu,et al.  Potential synergy of phytochemicals in cancer prevention: mechanism of action. , 2004, The Journal of nutrition.

[67]  P. Greenwald.  Cancer chemoprevention , 2002, BMJ : British Medical Journal.

[68]  T. Kensler.  Chemoprevention by inducers of carcinogen detoxication enzymes. , 1997, Environmental health perspectives.

[69]  T. Kakizoe.  Chemoprevention of cancer--focusing on clinical trials. , 2003, Japanese journal of clinical oncology.

[70]  D. Lamson,et al.  Antioxidants and cancer, part 3: quercetin. , 2000, Alternative medicine review : a journal of clinical therapeutic.

[71]  P. Schumacker,et al.  Reactive oxygen species in cancer cells: live by the sword, die by the sword. , 2006, Cancer cell.

[72]  Xiaocheng Wu,et al.  Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations , 2006, Cancer.

[73]  A. Kong,et al.  Dietary chemopreventive compounds and ARE/EpRE signaling. , 2004, Free radical biology & medicine.

[74]  Raj Kumar,et al.  Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). , 2003, International journal of oncology.